Nanomedicine & Drug Delivery Symposium (NanoDDS 2025)

Nanomedicine & Drug Delivery Symposium (NanoDDS 2025) will take place on October 27–28, 2025, at the Houston Methodist Research Institute in the Texas Medical Center, Houston, Texas and is co-chaired this year by Dr. Biana Godin, Dr. Francesca Taraballi and Dr. Alessandro Grattoni. NanoDDS is the first and one of the most important conferences in nanomedicine. Established over twenty years ago by Drs. Kabanov and Kataoka, it continues to be a premier forum for showcasing cutting-edge research and emerging technologies in drug delivery systems.

Building on its strong legacy, NanoDDS 2025 will bring together a multidisciplinary community of global experts, scientists, clinicians, and industry partners to foster collaboration and highlight the significant advancements in nanomedicine and drug delivery systems. This conference follows Houston Methodist’s tradition of hosting prestigious, highly visible symposia.

The objectives of the Nanomedicine and Drug Delivery Symposium are to discuss groundbreaking discoveries and developments in nanomedicine and drug/nucleic acid delivery; highlight clinical developments and opportunities for advancing nanomedicine technology to the marketplace; and engage and educate students, postdoctoral trainees and scientists locally, nationally and globally.

Co-sponsored by The George and Angelina Kostas Research Center for Cardiovascular Nanomedicine